Venus Remedies Ltd, a fast-growing pharmaceutical company in the country, has launched MEBATIC, a unique antibiotic combination in infusion form to cure severe gastro intestinal (GI) infections.
Launched with unique and distinct combination of Floroquinolone & Nitroimidazole, MEBATIC has been identified as the best solution for treating micro-organisms like anaerobes, aerobes and protozoa that cause diseases like watery diarrhea, dysentery, enteritis, traveler's diarrhea, and acute food poisoning.
MEBATIC INFUSION has shown 20 to 25 per cent improved efficacy over the existing therapies. The drug has also been developed with a ‘Chemical Vector’ that promotes faster recovery and ensures deeper penetration of antibiotic at the site of infection.
Anaerobes being difficult to detect and treat are a major cause of concern for medical fraternity practicing in India and across the globe. “More effective and innovative therapies like MEBATIC are needed as the micro-organisms are becoming increasingly resistant to the existing antibiotics like Metronidazole. Due to the increased drug resistance mortality associated with anaerobes in India has gone up to 24-31%, which is indeed a cause of concern,” said Dr. Manu Chaudhary Director and head Venus Medicine Research Center (VMRC), the R&D arm of Venus Remedies.
Indian Pharmaceutical market was USD 11.50 billion in 2008-09 and out of this the Gastrointestinal drugs segment contributes to 10.70% of total market making the GI market size of approx. 1.2305 billion USD.
MEBATIC is also the best choice available for pre and post surgical procedures, pelvic infections, urinary tract infections, uro-genital tract infections, typhoid & prevention of ICU infections, caused due to the presence of Anaerobes in the human body.
The drug has been approved by the Drugs Controller General of India (DCGI) after successful phase III comparative clinical trials conducted by VMRC.
More facts on the effect of gastro-intestinal infections --
According to the 2006 report, published by the Geneva-based organization an average of 1,250 people die each day in India from diarrhea-related diseases and 1,000 from tuberculosis. In developing countries, diarrhea related illnesses; especially those of prolonged duration are important causes of growth retardation and death. Episodes of diarrhea that usually resolves within few days in a normal case persist longer in malnourished and impaired cellular immunity or recurrent diarrhea.
Similarly, about 1.5 million children under five die of diarrhea every year. While the highest number of deaths occurs in Africa, of the total 38 per cent deaths that took place in South Asia in 2004, India accounted for the highest number of deaths. This has been revealed by a new report released by the United Nations and World Health Organization (WHO).
According to the report, pneumonia and diarrhea together account for an estimated 40 per cent of all child deaths around the world each year. Nearly one in five children die due to diarrhea, more than that caused by AIDS, malaria and measles combined.
Among the 15 countries of South Asia, India accounts for the highest number of deaths due to diarrhea, much above China, Pakistan and Bangladesh.
MEBATIC shows 20-25% more efficacy over existing therapies
| < Prev | Next > |
|---|
